Fund detail
Baillie Gifford
large-active, growth, lo
Quarters
52
2018-12-31
$76.98B
Positions
226
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tencent Music Entertainment ADR TME | $108.4M | 0.14% | 8,196,089 | +8,196,089 | 2018-12-31 | $13 | ~$13 | +0.00% | |||
| 2 | Anaplan Inc Common PLANUSD | $49.7M | 0.06% | 1,871,644 | +1,871,644 | 2018-12-31 | $27 | ~$27 | +0.00% | |||
| 3 | Moderna Inc MRNA | $26.4M | 0.03% | 1,725,844 | +1,725,844 | 2018-12-31 | $15 | ~$15 | +0.00% | |||
| 4 | BanColombia Pref ADR CIBEUR | $21.4M | 0.03% | 562,894 | +562,894 | 2014-03-31 | $38 | ~$55 | -30.35% | |||
| 5 | Axon Enterprise Inc AXON | $16.7M | 0.02% | 380,618 | +380,618 | 2018-12-31 | $44 | ~$44 | +0.00% | |||
| 6 | Orchard Therapeutics PLC ADR ORTXUSD | $14.6M | 0.02% | 925,000 | +925,000 | 2018-12-31 | $16 | ~$16 | +0.00% | |||
| 7 | Edwards Lifesciences Corp EW | $203K | 0.00% | 1,327 | +1,327 | 2018-12-31 | $153 | ~$153 | +0.00% |